Table 2. Prevalence and incidence of NAFLD in different regions.
| Continent | Country/region | Prevalence, % | Incidence, per 1,000 person-years |
|---|---|---|---|
| North America | 11.1–46.0 | Not available | |
| USA | 11.1–46.0 | Not available | |
| Mexico | 14.3 | Not available | |
| South America | 23.4–35.3 | Not available | |
| Brazil | 35.3 | Not available | |
| Colombia | 26.6 | Not available | |
| Chile | 23.4 | Not available | |
| Europe | 4.0–49.6 | 18.5 | |
| UK | 26.4 | Not available | |
| France | 26.8 | Not available | |
| Spain | 25.8 | Not available | |
| Italy | 4.0–49.6 | 18.5 | |
| Germany | 30.0 | Not available | |
| Romania | 20.0 | Not available | |
| Hungary | 22.6 | Not available | |
| Finland | 41.2 | Not available | |
| Netherlands | 33.9 | Not available | |
| Asia | 23.3–31.9 | 44.8–57.4 | |
| China | 12.5–29.9 | 47.0–81.3 | |
| Japan | 17.3–19.6 | 26.3–31.7 | |
| South Korea | 27.0–28.8 | 37.9–52.9 | |
| India | 10.0–25.0 | Not available | |
| Taiwan | 11.5–50.1 | Not available | |
| Hong Kong | 23.1–28.5 | 30.0–47.0 | |
| Singapore | 22.0–29.4 | Not available | |
| Malaysia | 22.7–49.6 | Not available | |
| Sri Lanka | 31.0–34.3 | Not available | |
| Middle East | 13.5–58.2 | Not available | |
| Saudi Arabia | 16.6–22.5 | Not available | |
| Turkey | 51.1–59.1 | Not available | |
| Israel | 23.9–39.5 | 19.34–40.57 | |
| Iran | 12.9–17.9 | Not available | |
| Africa | 5.7–28.7 | Not available | |
| Nigeria | 1.2–16.7 | Not available | |
| Sudan | 12.7–29.2 | Not available |
NAFLD, nonalcoholic fatty liver disease.